1. Controlled correspondence related to generic drug development Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2020 Subject(s): Correspondence as TopicDrug DevelopmentDrugs, GenericUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
